Skip to content

Net margin at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
15%+3.8pp
Pfizer logo
PfizerPFE
15.7%
Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
35.5%
Incyte logo
IncyteINCY
26.7%+26.2pp
BioMarin Pharmaceuticals logo
BioMarin PharmaceuticalsBMRN
16.8%+5.1pp
Precigen logo
PrecigenPGEN
-3,656%

Other financials

Income statement

See full
Revenue$20.7M+138%
Gross profit$19.4M+154%
Operating income-$110.0M-3.2%
Net income-$99.1M-11.0%
EPS (diluted)-$1.69-9.0%

Balance sheet

See full
Cash & equivalents$113.6M+43.9%
Total debt$35.7M-32.5%
Total equity$1.1B-24.4%
Total assets$1.2B-23.8%

Cash flow

See full
Operating cash flow-$118.9M-6.7%
CapEx$769.0K+0.4%
Free cash flow-$119.7M-6.6%

Valuation

See full
Market cap$2.12B+18.1%
Enterprise value$2.04B+15.2%
P/S32.1×-16.4×

Profitability

See full
Gross margin90%+2.5pp
Operating margin-720%-204pp
FCF margin-582.5%-185pp

Returns & leverage

See full
Return on equity-32.8%
Debt / equity0.0×
Current ratio14.2×-4.3×

Where this comes from

Calculated from Agios Pharmaceuticals’s reported figures.

Based on trailing twelve months.

The official record: Agios Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Agios Pharmaceuticals's net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Agios Pharmaceuticals's net margin?
Agios Pharmaceuticals (AGIO) reported net margin of -639.8% in Q1 2026.
What is the long-term trend for Agios Pharmaceuticals's net margin?
Over 2 years (2020 to 2025), Agios Pharmaceuticals's net margin has grown at a 117.8% compound annual growth rate (CAGR), from -161.1% to -764%.
What does net margin mean?
Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.